chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information was received from a pharmacist concerning a patient of unknown age. On an unknown date in the past, the patient was vaccinated with PNEUMOVAX 23. It was reported that the patient had an unspecified anaphylactic reaction after receiving PNEUMOVAX 23 in the past. No further information was reported. Additional information has been requested.
Pneumonia; A spontaneous report was received from a consumer concerning a 73-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced pneumonia.   The patient's medical history was not provided.  No relevant concomitant medications were reported.  On 12 Jan 2021, approximately six days prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number: 039K20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.    On 17 Jan 2021, the patient started experiencing cold symptoms. The patient had pneumonia and was hospitalized on 18 Jan 2021. Since the patient was taking antibiotics, healthcare professional recommended to wait on the second dose of the vaccine. The second dose was scheduled 49 days after the first one. The reporter stated that the patient was immunosuppressed. Treatment information included antibiotics.    Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the event, pneumonia, was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Case number PHEH2012US025225, is an initial spontaneous report received from a nurse on 20 Dec 2012. This case refers to a 15-year-old female patient. The medical history and concomitant medication of the patient were not reported. She was vaccinated with MENVEO (batch number: X11041) solution for injection, intramuscularly on 06 Dec 2012. The nurse reported that the patient received only meningococcal CYW-135 on 06 Dec 2012. No adverse event was reported following this mal administration.
Within 4 hours I was achy and felt unwell and by 10 PM I started with a fever and stomach cramping. Same thing happened as 2nd dose except I had terrible stomach pains and ended up in the bathroom and had blood in my stool which alarmed me. The next day I felt crummy and had a temperature and achiness but it followed the same pattern as the 2nd dose. First day I hurt so bad with stomach cramps, and the next day I had the fever and aching and at night I had stomach pains and blood in stool and by the 3rd morning I again had blood in stool so I went to the acute care clinic and they said to go to the ER for an MRI. I believe I went to local hospital and was in there the whole day, and they did an MRI and the Doctor stated I had a spontaneous colitis attack. He gave me pain pills and said that if it didn't go away I needed to come back in. That lasted 3 days total.
Was very sick for  both immunizations for about 24 hours. On July 14th began with fever and right lower quadrant pain. Went to Emergency room on the 16th of July with highly elevated liver enzymes, low grade fever, inflamed bile ducts. Possible Gall bladder infection. Was admitted on July 16th.  HIda scan showed no gall bladder filling.  I have had numerous testing , biopsies. a Repeat HIDA scan shows gallbladder now filling. I remain not feeling well.
Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Nausea-Mild, Additional Details: Patient felt faint within 5 min of administration, room was spinning and she felt as if she was going to pass out. Back of tongue swelled up. patient was given 2 tablets of benadryl and felt better after drive home. Symptoms stopped around evening
Slept after booster shot; Swelling of face after booster shot; Swelling of throat after booster shot; Difficulty swallowing after booster shot; Exhausted after booster shot; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Slept after booster shot), SWELLING FACE (Swelling of face after booster shot), PHARYNGEAL SWELLING (Swelling of throat after booster shot), DYSPHAGIA (Difficulty swallowing after booster shot) and FATIGUE (Exhausted after booster shot) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076B21A) for COVID-19 vaccination.     Concurrent medical conditions included Psoriasis and Autoimmune disorder.    On 23-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Oct-2021, the patient experienced SOMNOLENCE (Slept after booster shot), SWELLING FACE (Swelling of face after booster shot), PHARYNGEAL SWELLING (Swelling of throat after booster shot), DYSPHAGIA (Difficulty swallowing after booster shot) and FATIGUE (Exhausted after booster shot). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency; FAMOTIDINE (PEPCID [FAMOTIDINE]) for Adverse event, at an unspecified dose and frequency and LORATADINE (CLARITIN [LORATADINE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, SOMNOLENCE (Slept after booster shot), SWELLING FACE (Swelling of face after booster shot), PHARYNGEAL SWELLING (Swelling of throat after booster shot), DYSPHAGIA (Difficulty swallowing after booster shot) and FATIGUE (Exhausted after booster shot) outcome was unknown.            No concomitant medication were provided. Patient stated that he finished the antihistamines but his face was still swollen. Patient Thought was having allergic reaction after booster shot   Patient took his first dose on 08-Mar-2021, lot No. 036A21A and second dose on 05-Apr-2021 , lot No. 030B21A.   This case was linked to MOD-2021-366494, MOD-2021-366514 (Patient Link).
6 days post vax pt came in c/o 4x4 area of erythema w/o palpable mass; seen by MD started on Keflex x 10 days;
Immediate excruciating headache and earache, tingling disown my left arm to fingers and nauseated  I have continued to be sick since my vaccine Visited my doctor yesterday and was put on methyl prednisone
Rigors; Severe Fatigue; Headache; Myalgia; Nausea; Fever; This spontaneous case was reported by a physician assistant and describes the occurrence of CHILLS (Rigors), FATIGUE (Severe Fatigue), HEADACHE (Headache), MYALGIA (Myalgia) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Dec-2020, the patient experienced CHILLS (Rigors), FATIGUE (Severe Fatigue), HEADACHE (Headache), MYALGIA (Myalgia), NAUSEA (Nausea) and PYREXIA (Fever). At the time of the report, CHILLS (Rigors), FATIGUE (Severe Fatigue), HEADACHE (Headache), MYALGIA (Myalgia), NAUSEA (Nausea) and PYREXIA (Fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported. Treatment information not provided.
"a blotch of red bumps"; "not too comfortable"; frustrated; "I'm not feeling better"; "I don't know my body now"/a lot of strange things are happening"; "a blotch of red bumps"; a little itchy; been itching like crazy;  feel like a junky because I am scratching on one side and scratching on the other side; felt tired; "felt a little weak"; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA ("felt a little weak"), RASH MACULAR ("a blotch of red bumps"), DISCOMFORT ("not too comfortable"), FRUSTRATION TOLERANCE DECREASED (frustrated) and MALAISE ("I'm not feeling better") in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Glaucoma. Concomitant products included BIMATOPROST (LUMIGAN) for Glaucoma, VITAMIN C [ASCORBIC ACID] and CURCUMA LONGA (TURMERIC [CURCUMA LONGA]) for an unknown indication.    On 05-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jun-2021, the patient experienced ASTHENIA ("felt a little weak"), PRURITUS (a little itchy; been itching like crazy;  feel like a junky because I am scratching on one side and scratching on the other side) and FATIGUE (felt tired). On 07-Jun-2021, the patient experienced RASH MACULAR ("a blotch of red bumps"), DISCOMFORT ("not too comfortable"), FRUSTRATION TOLERANCE DECREASED (frustrated), MALAISE ("I'm not feeling better"), FEELING ABNORMAL ("I don't know my body now"/a lot of strange things are happening") and RASH ERYTHEMATOUS ("a blotch of red bumps"). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of 1 dosage form. At the time of the report, ASTHENIA ("felt a little weak"), RASH MACULAR ("a blotch of red bumps"), DISCOMFORT ("not too comfortable"), FRUSTRATION TOLERANCE DECREASED (frustrated), MALAISE ("I'm not feeling better"), RASH ERYTHEMATOUS ("a blotch of red bumps"), PRURITUS (a little itchy; been itching like crazy;  feel like a junky because I am scratching on one side and scratching on the other side) and FATIGUE (felt tired) outcome was unknown and FEELING ABNORMAL ("I don't know my body now"/a lot of strange things are happening") had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient took Blood Builder supplement  as concomitant product. patient took Benadryl to treat her symptoms.
Narrative:  97yo male patient who does not receive care from agency died on 9/10/2021. No medical information in pt's chart except pt did receive one covid vaccine from pharmacy on 1/14/2021. Likely this death is not related given patient's advanced age, and length of time between date of vaccine and date of death.
mild nausea; dizziness/dizzy; This is a spontaneous report from the Pfizer-Sponsored program,  received by a contactable consumer (patient).  A 71-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number E10142), via an unknown route, on 04Jan2021 at single dose in the left arm for COVID-19 immunisation. The patient received tetanus vaccine (at single dose in the right arm for tetanus immunization, due to overdue) in Dec2020 (3-4 weeks before vaccination for COVID-19). No additional medical history was provided. No relevant concomitant medications were provided. On 06Jan2021, she developed dizziness, she started feeling dizzy. On 07Jan2021, the patient developed mild nausea to the point that if she was laying on her right to turn on her left that her head was dizzy. The patient stated that she could not go in the bathroom at all last night because she could not make it due to dizziness. She stated that she had to pee in a cup. The patient reported that her niece, aged 27, with a history of vertigo also experienced severe dizziness after her first shot (reported under AER#2021015495). The patient had recovered from mild nausea on 07Jan2021 while she was recovering from dizziness/dizzy.
Pt reported to the E.R on 9/08/12 at 10:19 a.m. w/skin rash, swollen and tender Left upper extremity.  Dx w/hives, identified cause was his immunizations.
VACCINE WAS GIVEN BEYOND USE DATE. VACCINE WAS RECEIVED IN REFRIGERATOR ON 01/11/2022 AND KEPT IN APPROPRIATE TEMPERATURE (2-8 CELSIUS). VACCINE WAS ADMINISTERED TO PATIENT 14 DAYS PAST THE 30 DAY TIME IN REFRIGERATOR.
1st shot in 2/2020, start the series over; This case was reported by a consumer and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in February 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details provided were as follows: Age at vaccination was not applicable. Till the time of reporting, patient did not received 2nd dose which led to incomplete course of vaccination. The reporter wanted to know should he/she start the series over or just get the 2nd shot. Follow-up would not be possible as no contact details available.
Initial serious report received from a health care professional on 31 August 2007. A 37-year-old female with a history of childhood asthma had received an intramuscular injection of Fluzone (Lot number U2436AA) to her left arm at 6:00 AM on 31 August 2007. At 9:45 AM that same day, the patient felt tightness in her chest and shortness of breath, described as, "Like asthma attack". The patient had no illness at the time of vaccination and had not received any other vaccinations within four weeks prior to this event. It was reported that the patient was not taking any concomitant medications. Recovery status was reported as "Recovered". No additional information has been provided at the time of this report.
Mother of the patient state that the day after the vaccines administration the girl had developed a rash in both arms, thighs, legs and feet. The mother take the girl to her pediatrician and he evaluated her and referred her back to immunization clinic. The two days after the development of symptoms the rash have disappeared and the girl was alert and stable.
The same happen to another patient / his fingers went numb; This is a spontaneous report from another manufacturer company from contactable female consumer (patient). A female patient of unspecified age received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an intramuscular route on 28Apr2021 as dose 2, single in the left arm for covid-19 immunisation. The patient medical history was not reported. The patient concomitant medications included Medication for blood pressure. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on 21May2021 as dose 1, single for covid-19 immunisation. On unspecified date, the patient experienced that his fingers went numb. Patient called to report that after having the second dose of the vaccine on 28Apr2021 on the left, non-dominant arm, side effects developed. The same happen to another patient that received another covid19 vaccine. The patient wanted to knew what to do. The outcome of the event was unknown.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021650410
Day 8 - itchy at injection site with redness Day 10 - red rash at injection site (2"x2") - prickly heat feeling - no longer itchy
Patient claims the injection was given very high to the shoulder into the bursa sack, and she is still experiencing pain.
Patient reported red, swollen, painful area from shoulder to fingers. She noticed it right after the shot & it has gotten worse. I left a message with doctor & doctor will follow up with patient. The shot was sold on 11/27 at 13:29.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site swelling in a 66-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX (1st dose received, patient did not have reactions after the 1st dose). In September 2018, the patient received the 2nd dose of SHINGRIX. In September 2018, less than a week after receiving SHINGRIX, the patient experienced injection site swelling and injection site erythema. On an unknown date, the outcome of the injection site swelling and injection site erythema were unknown. It was unknown if the reporter considered the injection site swelling and injection site erythema to be related to SHINGRIX. Additional details were provided as follows: The patient received her 2nd dose of SHINGRIX 2 days ago and was having redness and swelling at the injection site which was about a 2x3 inch diameter.
PATIENT FELT DIZZY POST VACCINATION, WAS SWEATING.FELT WEAK. NO LOSS OF CONCIOUSNESS. INTERVENTION:  FELT BETTER AFTER PUTTING ON SUPINE POSITION WITH FEET ELEVATED
pt devel herpes zoster 19DEC96 & alleged that it is r/t recv flu vax 10OCT96;
My son received two vaccinations, Hib and HepB. He did not need either one of those shot.  I found out when I compared the shot record that they gave me today and the shot record from his previous pediatrician in Shreveport, that over 75% of his shot record had been entered incorrectly into their database. As I looked at the shot record they gave me today it had a 09/18/2009 date on their for the 1st HepA date.  Well that caught my eye because it's only June 2009. So I checked the entire shot record and 75% of the shot record provided by Napoleon Pediatrics had incorrect dates and some of the dates were missing.
At the time of the injection, I felt a burning sensation in my throat, then after about 6 hours a general malaise throughout the body, a lot of headache and at dawn a fever of 101.1. The same symptoms persisted on Monday as well. Tuesday morning fever to 101, but no pain in the body and less headache, and discouragement (motivation)?
Fever lasting two days that started *four days after* injection. Fever ranged between 100.5 - 101. General listlessness, loss of appetite.
pt began complaining of extreme pain in her left arm the evening of her injection, so much so that her son took her to the emergency room.  Morphine was given and pt still in extreme pain.  It was determined that pt had severe infection.  ER doctor, infectious disease doctor and pt's family doctor said she almost died. Upon discharge, pt is on antibiotic home infusion.
The night before I felt a heaviness in my chest, trouble breathing and the next morning I felt the same. I called my PCP and had a EKG and Covid swab (negative).  She prescribed me steroids'.
Was given MMR & DTAP into left deltoid & VARICELLA & IPV in right  PT got 10 X 10 area of erythema on left deltoid & a headache
101 days after being vaccinated I suffered two strokes January 31,2022 and February 1, 2022.  The second stroke to the back of my brain affected my left peripheral vision. I was treated for the first stroke in Hospital and then admitted to the hospital. I suffered the second stroke in the hospital the next morning. All test and scans were done in the Hospital. I then had rehab in the hospital as an inpatient. I also had outpatient rehab with the Visiting Nurse service while at home. I was in the hospital from Jan 31, 2022, to Feb 11, 2022.
Information has been received from a licensed practical nurse concerning a patient who on 12-JAN-2009 was vaccinated with PNEUMOVAX (lot number 662663/0980X). The patient developed severe cellulitis reactions immediately after or by the evening of the PNEUMOVAX administration. The patient had symptoms, which included swelling, redness and heat at the injection site. The patient also experienced pain and weakness. The patient sought medical attention at a express clinic or the emergency room. The patient was prescribed TYLENOL for the pain. The patient was treated for cellulitis and was put either on an (unspecified) antibiotic and/or (unspecified) steroid. The outcome of the patient's adverse reaction was not reported. The nurse requested a lot check. Follow-up information was received from an office manager who confirmed that several patients had injection site reactions. A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. The lot met the Agency and was released. This is one of several reports received from the same source. Additional information has been requested.
Patient fell down and wouldn't breathe. Was turning blue and hands and feet were drawing up. Body was limp.  Lasted about 30 seconds or so. Took one small breath but was still unresponsive then started breathing again. Called pediatrician and took to hospital, was seen in ER by doctor. No treatment.
6AUG91 9AM DTP/OPV/HIB given; @ 6PM 6AUG91 pt convuls, vomited & aspirated & fell between bed & wall & suffocated; Babysitter revived  pt & called rescue; Taken to ER for 1 hr then to Hosp & admitted through 8AUG91;
Patient presented to ED and subsequently hospitalized on 3/20/2021, and has not yet been discharged.
I started feeling body aches at 3 PM Friday, that progressed to chills and sweats by 5PM. These flu-like symptoms started to abate the next day (Saturday by noon) and I felt drained the rest of the day. I felt normal by the day after (Sunday).
The pt received an injection of Engerix-B on 10/19/00. That evening, the injection site became red and raised. The next day, the redness extended to the pt's left shoulder and he developed an upper respiratory infection. He was seen by a physician on 10/27/00. That day, he was hospitalized in an ICU, reportedly with the dx of  "CHF related to vaccine". He was treated with Glucophage and Lasix. The pt was discharged from the hospital on 10/28/00. The upper respiratory infection, injection site redness and injection site swelling resolved. The pt was seen by a physician on 12/6/00; his lungs were reportedly clear, at that time.
Patient received dose 2 of Moderna Covid-19 vaccine too soon, 19 days after first dose.   "Consider doses as vaccine administration errors if administered before the grace period (i.e., 23 days or less after the first dose). These doses do not need to be repeated but must be reported to VAERS."
Information has been received from a wholesaler calling on behalf of physician concerning three patients who were each vaccinated SC with a dose of pneumococcal vaccine 23 polyvalent. Subsequently, the patients developed inflammation around the injection site that included redness and soreness. Unspecified medical attention was sought. A product quality complaint was not involved. Follow up information was received from an MD concerning the three pt(s), which included a 69 year old patient, who between 01JUN2003 and 04JUN2003 were each vaccinated SC with a a dose of pneumococcal vaccine 23 polyvalent. Subsequently in approximately June 2003, all three pts developed local swelling, malaise and were not feeling well, "i.e. local reaction". Within three to five days, all three pts had recovered with no residual problems. The reporter noted, "we had 2 more bottles of the same batch, will return". The records of testing prior to release of this lot have been checked by QA and found be to satisfactory. The lot complies with the standards of the Center for Biologics Evaluation and Research and was released. The other two patients included a 68 year old patient and an 89 year old patient. Additional information has been requested.
Pt presented to the pharmacy on 4/28/21 with redness, warm to the touch, slight swelling at the injection site. The redness was about baseball sized in diameter around injection site. It had grown and gotten worse over 2-3 days but the swelling was going down after the 3rd day. Pt had applied compresses to the site and was advised they could take OTC tylenol to decrease pain. Was advised if it gets worse instead of better to seek treatment at the dr or ER if needed. Advised patient that this is overall a reported adverse effect of the vaccine and for patient to return if it got worse.